Even Healthcare funding values startup at $300M after $50M raise

The funding round is a signal that investors think Even Healthcare’s approach to tackling hospital economics in India could alter how care is delivered and paid for. Even has raised more than $120 million in total and now aims to expand its footprint beyond its two Bengaluru hospitals, moving toward new facilities and a broader patient base.

Even’s core idea is to shift incentives away from generating more tests and longer stays. Instead, the startup pays doctors fixed salaries and rewards good clinical outcomes, not the volume of procedures. It also ties hospital management compensation to company-wide metrics rather than individual patient revenues. The goal is to deliver higher quality care while reducing unnecessary costs for insurers and patients alike.

Founder Mayank Banerjee described a move from partner hospitals to in-house hospital operations as a key turning point. He said this model allows Even to align clinical decisions with better outcomes and lower overall costs, rather than letting revenue incentives drive care. The company is also experimenting with partnerships with insurers to compensate for hospitalizations it helps prevent, rather than paying only for performed tests or procedures.

The funding comes as Indian hospitals typically earn more when patients receive additional tests or stay longer. Even’s two Bengaluru hospitals reached operational profitability, excluding depreciation, within a year of opening, Banerjee noted. The plan is to open five more hospitals in Bengaluru over the next six months, financed by the new round.

As with any health-tech model, questions remain about scale, profitability, and how insurer partnerships will work out in practice. Even posted a net loss in fiscal 2025, though it also reported improving metrics like a low unplanned readmission rate and shorter patient stays. Investors say the results to date justify backing the expansion, even as the company continues to refine its economics.

For readers in the United States, United Kingdom, or Canada, the broader takeaway is how venture funding can push hospital groups to rethink incentives around tests and procedures. If Even’s model proves sustainable, it could influence international conversations about how to reward better health outcomes and reduce waste in care delivery.